For healthcare professionals
Re2O information for clinics and healthcare professionals
Request product documentation and connect with our team about clinical literature and professional education.
What you can request
- Product information and documentation.
- Traceability information.
- The clinical paper, trial registration and safety literature.
- Professional education and training information.
- A contact for product-quality questions and adverse-event reporting.
Review the material and the evidence
Re2O is a human-derived acellular dermal matrix. Its material characteristics and risk profile need to be considered in their own right. The available split-face trial evaluated particulated human ADM mixed with HA, not ADM monotherapy. A subsequent case report describes a vascular complication following Re2O injection. Review the research summary and sources.
The site’s summaries do not replace current product documentation, professional training or clinical judgement. Product preparation, injection technique and complication management belong in the appropriate professional documentation and training setting.